1 |
Pagilla S, Anagani Kanaka Durga B, Vodnala S, Kamutam R, Mudiraj A, Phanithi PB, Chetti P. Identification of novel quinazolinone hybrids as cytotoxic agents against C6 glioma cell lines. J Chinese Chemical Soc 2022;69:968-78. [DOI: 10.1002/jccs.202200058] [Reference Citation Analysis]
|
2 |
Khan K, Jalal K, Khan A, Al-Harrasi A, Uddin R. Comparative Metabolic Pathways Analysis and Subtractive Genomics Profiling to Prioritize Potential Drug Targets Against Streptococcus pneumoniae. Front Microbiol 2021;12:796363. [PMID: 35222301 DOI: 10.3389/fmicb.2021.796363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
3 |
Chitti S, Van Calster K, Cappoen D, Nandikolla A, Khetmalis YM, Cos P, Kumar BK, Murugesan S, Gowri Chandra Sekhar KV. Design, synthesis and biological evaluation of benzo-[ d ]-imidazo-[2,1- b ]-thiazole and imidazo-[2,1- b ]-thiazole carboxamide triazole derivatives as antimycobacterial agents. RSC Adv 2022;12:22385-401. [DOI: 10.1039/d2ra03318f] [Reference Citation Analysis]
|
4 |
Dhameliya TM, Bhakhar KA, Gajjar ND, Patel KA, Devani AA, Hirani RV. Recent advancements and developments in search of anti-tuberculosis agents: A quinquennial update and future directions. Journal of Molecular Structure 2022;1248:131473. [DOI: 10.1016/j.molstruc.2021.131473] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
5 |
Belen’kii LI, Gazieva GA, Evdokimenkova YB, Soboleva NO. The literature of heterocyclic chemistry, Part XX, 2020. Advances in Heterocyclic Chemistry 2022. [DOI: 10.1016/bs.aihch.2022.10.005] [Reference Citation Analysis]
|